Middle East & Africa Urinary Incontinence Therapeutics Market Size & Outlook
Related Markets
MEA urinary incontinence therapeutics market highlights
- The MEA urinary incontinence therapeutics market generated a revenue of USD 163.7 million in 2024.
- The market is expected to grow at a CAGR of 4.4% from 2025 to 2033.
- In terms of segment, stress incontinence was the largest revenue generating type in 2024.
- Urge Incontinence is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 163.7 million |
| Market revenue in 2033 | USD 241.3 million |
| Growth rate | 4.4% (CAGR from 2025 to 2033) |
| Largest segment | Stress incontinence |
| Fastest growing segment | Urge Incontinence |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence, Other |
| Key market players worldwide | Pfizer Inc, AbbVie Inc, Astellas Pharma Inc, Johnson & Johnson, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sanofi SA, GlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Boehringer Ingelheim Pharma, Bayer AG, Ferring |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.8% of the global urinary incontinence therapeutics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,769.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Urinary Incontinence Therapeutics Market Scope
Urinary Incontinence Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Middle East & Africa urinary incontinence therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to urinary incontinence therapeutics market will help companies and investors design strategic landscapes.
Stress incontinence was the largest segment with a revenue share of 31.4% in 2024. Horizon Databook has segmented the Middle East & Africa urinary incontinence therapeutics market based on stress incontinence, urge incontinence, overflow incontinence, functional incontinence, other covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa urinary incontinence therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa urinary incontinence therapeutics market databook
-
Our clientele includes a mix of urinary incontinence therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa urinary incontinence therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa urinary incontinence therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA urinary incontinence therapeutics market size, by country, 2021-2033 (US$M)
Middle East & Africa Urinary Incontinence Therapeutics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
